Department of Pediatrics Archive — Page 26 of 58
-
February 28, 2022
Study finds azithromycin use during RSV not useful in preventing recurrent wheezing, may cause harm
Vanderbilt research on the impact of the antibiotic azithromycin during severe respiratory syncytial virus (RSV) bronchiolitis overwhelmingly support current national bronchiolitis guidelines, which recommend against antibiotics during acute bronchiolitis due to lack of effect on the acute illness. -
February 24, 2022
MIS-C diagnosis rare in vaccinated children with no previous COVID-19 diagnosis
A Vanderbilt study found that children who received the COVID-19 vaccine who had not previously been diagnosed with COVID infection are unlikely to be diagnosed with multisystem inflammatory syndrome in children (MIS-C). -
February 24, 2022
Study to explore neurologic impact of flu treatment
A Vanderbilt study will explore the neurologic and psychiatric complications of flu and evaluate adverse effects of the antiviral treatment oseltamivir, also known by the brand name Tamiflu. -
February 17, 2022
VUMC recognized for antimicrobial drug stewardship efforts
-
February 10, 2022
New insights into hypothalamic obesity
A common Type 2 diabetes treatment being tested for hypothalamic obesity had unexpected results on weight loss and total energy expenditure, Vanderbilt researchers report. -
February 10, 2022
Rush named among 2022 Women of Influence
Meg Rush, MD, MMHC, President of Monroe Carell Jr. Children’s Hospital at Vanderbilt, has been named a 2022 Women of Influence by Nashville Business Journal (NBJ). -
February 3, 2022
Study finds shorter treatment better for young children with outpatient pneumonia
A Vanderbilt study found that five days of antibiotics is superior to 10 days for children with community-acquired pneumonia who are not hospitalized.